To build an ABA public statement and evidence claim review system, inventory every channel and accountable speaker, classify the purpose, extract express and implied claims, and connect each claim to current evidence. Verify credentials, permissions, privacy, material connections, accessibility, and approval before dissemination. Preserve the released version, monitor reuse and complaints, and correct inaccurate statements across every dependent channel without erasing the original record.

Define Pilar's statement unit and audience

A public-statement system treats each message as a controlled claim with a speaker, evidence, audience, and lifecycle. Teams asking how to build an ABA public statement and evidence claim review system need the exact draft, full surrounding message, speaker, represented role, audience, channel, purpose, evidence date, permission state, disclosure, approver, and correction trigger before release.

Build Pilar's public-statement review system

Create one register with statement ID, speaker, represented role, organization, audience, channel, purpose, draft, each express and implied claim, evidence owner, source and date, population and limits, credential claim, client-data state, authorization or de-identification basis, sponsorship, accessibility review, approval, release locations, reuse rights, monitoring, complaint route, correction owner, and retirement date. High-risk health, safety, outcome, comparison, testimonial, and client-case claims require specialist review before release.

Protect clients and audiences in Pilar's review

Across Pilar's websites, directories, brochures, social posts, presentations, interviews, recruiting, and payer-facing materials, protect client dignity, privacy, communication authorship, consent and authorization where required, disability and language access, fair representation, current credentials, evidence limits, and clear disclosures. Hold unsupported or unauthorized content instead of relying on a footnote to neutralize the main message.

Work through Pilar's fictional example

Pilar locks 30 proposed statements. Twenty-one clear claim, evidence, permission, privacy, disclosure, and access gates. Five return for narrower wording or stronger evidence. Two need a valid privacy route. One needs a material-connection disclosure, and one remains held because the claimed outcome cannot be substantiated. Preserve every proposed, revised, approved, released, reused, corrected, retracted, retired, held, and unresolved unit with its original version, evidence, permissions, owner, dates, channels, and validation.

Use Pilar's denominator carefully

Initial release readiness is 21 of 30, or 70%. The nine returned or held statements remain in the original cohort. Approval, dissemination, audience reach, correction, and outcome are later states with their own denominators.

Assign Pilar's decisions to qualified owners

Pilar's content owner coordinates review. Qualified clinical and research reviewers interpret evidence. Privacy, legal, consumer-protection, licensing, employment, access, and organizational owners decide within scope. The named speaker confirms the final words and represented role; software cannot approve a claim.

Address Pilar's main interpretation risk

A sentence can be literally true while its image, headline, omitted limit, or placement creates a broader implied claim. Review the full communication as an audience will encounter it.

Verify Pilar's public control before release

Pilar tests one credential claim, one outcome claim, one client example, one testimonial, and one live-event statement. A second reviewer states the message they take away, locates its evidence and disclosure, and checks the released channel. Any mismatch triggers a focused rewrite or hold.

Place Pilar's review inside organizational accountability

For Pilar's public-statement review system, the CASP Organizational Guidelines public overview provides high-level business, clinical-operations, and risk-management scope for autism service organizations. CASP sells the detailed guidelines. This article's claim controls are Finni's editorial design, not a CASP marketing rule, legal conclusion, or approval of any statement.

Apply professional-statement duties to Pilar's actual role

Pilar's speaker analysis starts with role and scope. The current BACB Ethics Code applies to BCBA and BCaBA certificants and people who completed an application and addresses public statements, intellectual property, confidentiality, competence, and accuracy. BACB has no separate organization or corporation jurisdiction, so entity, workforce, legal, and channel controls remain necessary.

Test the overall advertising message for Pilar

Pilar's advertising review uses the FTC small-business advertising FAQ, which says advertising must be truthful and nondeceptive, objective claims need a reasonable basis before dissemination, and express and implied messages matter in context. It also explains that health or safety claims generally require competent and reliable scientific evidence. Apply the actual speaker, entity, medium, claim, and jurisdiction.

Match Pilar's health claim to its evidence

The FTC Health Products Compliance Guidance is staff business guidance without the force of law and says its principles apply to marketing of health-related products. It emphasizes accurate express and implied claims, appropriate scientific support, relevant population and outcome evidence, and limits on testimonials. It creates no safe harbor for Pilar.

Handle endorsements and reviews separately for Pilar

The FTC endorsements, influencers, and reviews page points to current Endorsement Guides and the Consumer Reviews and Testimonials Rule. It highlights material-connection disclosure and genuine consumer feedback. Pilar should verify the actual rule, relationship, review practice, platform, and date rather than treating an honest opinion as substantiation.

Require prior support for Pilar's objective claim

The FTC Advertising Substantiation Policy Statement states that advertisers need a reasonable basis for objective express and implied claims before dissemination and at least the level of support they claim. Pilar's approval record should therefore exist before release; a later study, disclaimer, guarantee, or satisfied customer does not retroactively supply the missing basis.

Classify HIPAA marketing for Pilar

Pilar's HIPAA marketing review starts with entity status. HHS marketing guidance explains that marketing uses or disclosures of PHI by covered entities generally require an individual's written authorization, with defined exceptions. Determine the activity, remuneration, recipient, and purpose. A clinical consent, testimonial agreement, or public post does not automatically authorize every marketing use or downstream reuse.

Prove de-identification rather than assuming it for Pilar

For HIPAA covered entities, HHS de-identification guidance recognizes Expert Determination and Safe Harbor methods and explains that properly de-identified data retains a very small residual risk. Pilar should document the method, provenance, limitations, and other-law or contractual constraints; deleting names or combining cases is not a method by itself.

Make Pilar's released message usable

For covered title II or title III entities, DOJ effective-communication guidance explains that aids and services depend on the nature, length, complexity, context, and person's usual communication method. Apply the actual entity and rule. Pilar's claims, evidence limits, sponsorships, corrections, and privacy choices should be accessible in the format where the audience receives them.

Choose Pilar's next review trigger

Review after new evidence, changed credential or role, reused content, complaint, privacy request, source correction, payer change, adverse event, broken disclosure, inaccessible format, or expired approval. Record the changed fact, affected statement and audience, immediate containment, source and permission state, qualified owner, correction need, channels, and validation result.

Close Pilar's public-statement record with evidence

Review the public-statement review system with Pilar, qualified clinical and organizational leaders, the named speaker or author, affected clients or representatives as applicable, and the specialists named in the manifest. Confirm that personal, professional, organizational, educational, marketing, research, testimony, privacy, and employment routes remain distinct; every claim and disclosure is traceable; accessibility is tested; and unresolved content has an accountable endpoint. Keep this page draft and noindex until every required review is complete.

Related resources

Sources